Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Nab-paclitaxel-based chemotherapy with or without anti-PD-(L)1 immunotherapy as a second-line treatment for advanced biliary tract cancer: a real-world retrospective study

Nan Zhou, Xinyi Li, Mingyou Gao [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2018

Tumour necrosis factor,interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice

Efimia Boutsikou, Kalliopi Domvri, Georgia Hardavella [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

A Single-Arm Multi-Center Phase II Clinical Trial of Cadonilimab (anti-PD-1/CTLA-4) in Combination with or without Conventional Second-Line Treatment for Patients with Extensive Stage Small Cell Lung Cancer

Can Chen, Minjun Chen, Yuju Bai [...]

Technology in Cancer Research & Treatment

Open access

Brief report

First published 2020

Pembrolizumab for the treatment of uveal melanoma: A case series

Yanina Jeanne Leona Jansen, Teofila Seremet, Bart Neyns

Rare Tumors

Open access

Review article

First published 2021

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Jingjing Qu, Quanhui Mei, Li Liu [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2021

PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research

Yu Zhang, Guang-Ze Mou, Tian-Zhu Li [...]

Technology in Cancer Research & Treatment

Retricted access

Review article

First published 2021-8

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Free access

Research article

First published 2014-7

PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy

Dawn E. Dolan, Shilpa Gupta

Cancer Control

Retricted access

Research article

First published 2017-03

Novel Treatment of Melanoma: Combined Parasite-Derived Peptide GK-1 and Anti-Programmed Death Ligand 1 Therapy

Jesus Vera-Aguilera, Armando Perez-Torres, Diego Beltran [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2023-4

Combination of anti-PD-L1 and radiotherapy in hepatocellular carcinoma: a mathematical model with uncertain parameters

Sajad Shafiekhani, Nematollah Gheibi, Azam Janati Esfahani

SIMULATION

Search results